Lower respiratory tract lactoferrin and lysozyme arise primarily in the airways and are elevated in association with chronic bronchitis

Austin Bassett Thompson, T. Bohling, F. Payvandi, S. I. Rennard

Research output: Contribution to journalArticle

119 Citations (Scopus)

Abstract

Lactoferrin and lysozyme are proteins found in high concentrations on mucosal surfaces, and they have activities potentially important for the modulation of inflammation. To investigate whether these proteins might contribute to the modulation of the intraluminal airway inflammation associated with chronic bronchitis, lactoferrin and lysozyme were measured in bronchoalveolar lavage (BAL) fluid from 22 subjects with chronic bronchitis and, for comparison, with 10 symptom-free smokers and 16 normal subjects. As a further control, transferrin, a protein structurally homologous to lactoferrin but not known to arise in airway epithelial cells, was also measured. BAL was performed by sequentially instilling and retrieving five 20 ml aliquots of normal saline solution into each of three sites. Analyzing the first aliquots separately from the later four provided fluid that was enriched for airway contents. The concentration of lactoferrin (11.83 ± 2.86 μg/ml vs 0.68 ± 0.18 μg/ml, p <0.00001), and lysozyme (6.75 ± 1.51 μg/ml vs 0.52 ± 0.09 μg/ml, p < 0.00001), but not transferrin (3.22 ± 0.38 μg/ml vs 2.68 ± 0.24 μg/ml, p = 0.55) was higher in the bronchial sample lavage fluid, suggesting an airway origin for lactoferrin and lysozyme. In subjects with chronic bronchitis, bronchial sample lactoferrin (23.1 ± 0.5 μg/ml) and lysozyme (12.6 ± 3.5 μg/ml) were elevated compared with the normal subjects' lactoferrin (1.9 ± 0.5 μg/ml, p <0.0001) and lysozyme (0.77 ± 0.22 μg/ml, p<0.0001) and the symptom-free smokers'lactoferrin (4.1 ± 0.8 μg/ml, p = 0.005) and lysozyme (4.9 ± 1.3 μg/ml, p = 0.02). Transferrin concentrations did not demonstrate the same relationships. Finally, when the content of bronchial sample lactoferrin and lysozyme were compared with the content of bronchial sample neutrophils, poor correlations were found, which may imply an airway epithelial origin for the two proteins. Thus lactoferrin and lysozyme appear to arise in the lower respiratory tract within the airways and their levels are elevated in association with chronic bronchitis. This suggests that lactoferrin and lysozyme may contribute to the modulation of airway inflammation in chronic bronchitis.

Original languageEnglish (US)
Pages (from-to)148-158
Number of pages11
JournalJournal of Laboratory and Clinical Medicine
Volume115
Issue number2
StatePublished - Jan 1 1990

Fingerprint

Lactoferrin
Chronic Bronchitis
Muramidase
Respiratory System
Transferrin
Bronchoalveolar Lavage Fluid
Modulation
Inflammation
Fluids
Proteins
Bronchoalveolar Lavage
Sodium Chloride
Neutrophils
Epithelial Cells

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Lower respiratory tract lactoferrin and lysozyme arise primarily in the airways and are elevated in association with chronic bronchitis. / Thompson, Austin Bassett; Bohling, T.; Payvandi, F.; Rennard, S. I.

In: Journal of Laboratory and Clinical Medicine, Vol. 115, No. 2, 01.01.1990, p. 148-158.

Research output: Contribution to journalArticle

@article{d44ded2fc4e14cffa77d2980baed2a5a,
title = "Lower respiratory tract lactoferrin and lysozyme arise primarily in the airways and are elevated in association with chronic bronchitis",
abstract = "Lactoferrin and lysozyme are proteins found in high concentrations on mucosal surfaces, and they have activities potentially important for the modulation of inflammation. To investigate whether these proteins might contribute to the modulation of the intraluminal airway inflammation associated with chronic bronchitis, lactoferrin and lysozyme were measured in bronchoalveolar lavage (BAL) fluid from 22 subjects with chronic bronchitis and, for comparison, with 10 symptom-free smokers and 16 normal subjects. As a further control, transferrin, a protein structurally homologous to lactoferrin but not known to arise in airway epithelial cells, was also measured. BAL was performed by sequentially instilling and retrieving five 20 ml aliquots of normal saline solution into each of three sites. Analyzing the first aliquots separately from the later four provided fluid that was enriched for airway contents. The concentration of lactoferrin (11.83 ± 2.86 μg/ml vs 0.68 ± 0.18 μg/ml, p <0.00001), and lysozyme (6.75 ± 1.51 μg/ml vs 0.52 ± 0.09 μg/ml, p < 0.00001), but not transferrin (3.22 ± 0.38 μg/ml vs 2.68 ± 0.24 μg/ml, p = 0.55) was higher in the bronchial sample lavage fluid, suggesting an airway origin for lactoferrin and lysozyme. In subjects with chronic bronchitis, bronchial sample lactoferrin (23.1 ± 0.5 μg/ml) and lysozyme (12.6 ± 3.5 μg/ml) were elevated compared with the normal subjects' lactoferrin (1.9 ± 0.5 μg/ml, p <0.0001) and lysozyme (0.77 ± 0.22 μg/ml, p<0.0001) and the symptom-free smokers'lactoferrin (4.1 ± 0.8 μg/ml, p = 0.005) and lysozyme (4.9 ± 1.3 μg/ml, p = 0.02). Transferrin concentrations did not demonstrate the same relationships. Finally, when the content of bronchial sample lactoferrin and lysozyme were compared with the content of bronchial sample neutrophils, poor correlations were found, which may imply an airway epithelial origin for the two proteins. Thus lactoferrin and lysozyme appear to arise in the lower respiratory tract within the airways and their levels are elevated in association with chronic bronchitis. This suggests that lactoferrin and lysozyme may contribute to the modulation of airway inflammation in chronic bronchitis.",
author = "Thompson, {Austin Bassett} and T. Bohling and F. Payvandi and Rennard, {S. I.}",
year = "1990",
month = "1",
day = "1",
language = "English (US)",
volume = "115",
pages = "148--158",
journal = "Translational Research",
issn = "1931-5244",
publisher = "Mosby Inc.",
number = "2",

}

TY - JOUR

T1 - Lower respiratory tract lactoferrin and lysozyme arise primarily in the airways and are elevated in association with chronic bronchitis

AU - Thompson, Austin Bassett

AU - Bohling, T.

AU - Payvandi, F.

AU - Rennard, S. I.

PY - 1990/1/1

Y1 - 1990/1/1

N2 - Lactoferrin and lysozyme are proteins found in high concentrations on mucosal surfaces, and they have activities potentially important for the modulation of inflammation. To investigate whether these proteins might contribute to the modulation of the intraluminal airway inflammation associated with chronic bronchitis, lactoferrin and lysozyme were measured in bronchoalveolar lavage (BAL) fluid from 22 subjects with chronic bronchitis and, for comparison, with 10 symptom-free smokers and 16 normal subjects. As a further control, transferrin, a protein structurally homologous to lactoferrin but not known to arise in airway epithelial cells, was also measured. BAL was performed by sequentially instilling and retrieving five 20 ml aliquots of normal saline solution into each of three sites. Analyzing the first aliquots separately from the later four provided fluid that was enriched for airway contents. The concentration of lactoferrin (11.83 ± 2.86 μg/ml vs 0.68 ± 0.18 μg/ml, p <0.00001), and lysozyme (6.75 ± 1.51 μg/ml vs 0.52 ± 0.09 μg/ml, p < 0.00001), but not transferrin (3.22 ± 0.38 μg/ml vs 2.68 ± 0.24 μg/ml, p = 0.55) was higher in the bronchial sample lavage fluid, suggesting an airway origin for lactoferrin and lysozyme. In subjects with chronic bronchitis, bronchial sample lactoferrin (23.1 ± 0.5 μg/ml) and lysozyme (12.6 ± 3.5 μg/ml) were elevated compared with the normal subjects' lactoferrin (1.9 ± 0.5 μg/ml, p <0.0001) and lysozyme (0.77 ± 0.22 μg/ml, p<0.0001) and the symptom-free smokers'lactoferrin (4.1 ± 0.8 μg/ml, p = 0.005) and lysozyme (4.9 ± 1.3 μg/ml, p = 0.02). Transferrin concentrations did not demonstrate the same relationships. Finally, when the content of bronchial sample lactoferrin and lysozyme were compared with the content of bronchial sample neutrophils, poor correlations were found, which may imply an airway epithelial origin for the two proteins. Thus lactoferrin and lysozyme appear to arise in the lower respiratory tract within the airways and their levels are elevated in association with chronic bronchitis. This suggests that lactoferrin and lysozyme may contribute to the modulation of airway inflammation in chronic bronchitis.

AB - Lactoferrin and lysozyme are proteins found in high concentrations on mucosal surfaces, and they have activities potentially important for the modulation of inflammation. To investigate whether these proteins might contribute to the modulation of the intraluminal airway inflammation associated with chronic bronchitis, lactoferrin and lysozyme were measured in bronchoalveolar lavage (BAL) fluid from 22 subjects with chronic bronchitis and, for comparison, with 10 symptom-free smokers and 16 normal subjects. As a further control, transferrin, a protein structurally homologous to lactoferrin but not known to arise in airway epithelial cells, was also measured. BAL was performed by sequentially instilling and retrieving five 20 ml aliquots of normal saline solution into each of three sites. Analyzing the first aliquots separately from the later four provided fluid that was enriched for airway contents. The concentration of lactoferrin (11.83 ± 2.86 μg/ml vs 0.68 ± 0.18 μg/ml, p <0.00001), and lysozyme (6.75 ± 1.51 μg/ml vs 0.52 ± 0.09 μg/ml, p < 0.00001), but not transferrin (3.22 ± 0.38 μg/ml vs 2.68 ± 0.24 μg/ml, p = 0.55) was higher in the bronchial sample lavage fluid, suggesting an airway origin for lactoferrin and lysozyme. In subjects with chronic bronchitis, bronchial sample lactoferrin (23.1 ± 0.5 μg/ml) and lysozyme (12.6 ± 3.5 μg/ml) were elevated compared with the normal subjects' lactoferrin (1.9 ± 0.5 μg/ml, p <0.0001) and lysozyme (0.77 ± 0.22 μg/ml, p<0.0001) and the symptom-free smokers'lactoferrin (4.1 ± 0.8 μg/ml, p = 0.005) and lysozyme (4.9 ± 1.3 μg/ml, p = 0.02). Transferrin concentrations did not demonstrate the same relationships. Finally, when the content of bronchial sample lactoferrin and lysozyme were compared with the content of bronchial sample neutrophils, poor correlations were found, which may imply an airway epithelial origin for the two proteins. Thus lactoferrin and lysozyme appear to arise in the lower respiratory tract within the airways and their levels are elevated in association with chronic bronchitis. This suggests that lactoferrin and lysozyme may contribute to the modulation of airway inflammation in chronic bronchitis.

UR - http://www.scopus.com/inward/record.url?scp=0025255103&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025255103&partnerID=8YFLogxK

M3 - Article

C2 - 2299262

AN - SCOPUS:0025255103

VL - 115

SP - 148

EP - 158

JO - Translational Research

JF - Translational Research

SN - 1931-5244

IS - 2

ER -